Edwards Lifesciences (EW) Raw Materials (2016 - 2025)
Edwards Lifesciences has reported Raw Materials over the past 12 years, most recently at $196.6 million for Q4 2025.
- Quarterly results put Raw Materials at $196.6 million for Q4 2025, down 18.46% from a year ago — trailing twelve months through Dec 2025 was $196.6 million (down 18.46% YoY), and the annual figure for FY2025 was $196.6 million, down 18.46%.
- Raw Materials for Q4 2025 was $196.6 million at Edwards Lifesciences, down from $222.8 million in the prior quarter.
- Over the last five years, Raw Materials for EW hit a ceiling of $280.0 million in Q1 2024 and a floor of $196.3 million in Q4 2023.
- Median Raw Materials over the past 3 years was $241.1 million (2024), compared with a mean of $236.5 million.
- Biggest five-year swings in Raw Materials: grew 22.82% in 2024 and later decreased 18.46% in 2025.
- Edwards Lifesciences' Raw Materials stood at $196.3 million in 2023, then rose by 22.82% to $241.1 million in 2024, then decreased by 18.46% to $196.6 million in 2025.
- The last three reported values for Raw Materials were $196.6 million (Q4 2025), $222.8 million (Q3 2025), and $249.8 million (Q2 2025) per Business Quant data.